NEWSROOM
Blog
Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study
Case Series represents second study showing VitaGraft Kidney as a measure of response to the benefit of therapy for one leading cause of allograft failure
BioStem Technologies Reports Record Second Quarter 2024 Revenue of $74.5 Million
POMPANO BEACH, FL, 2024 — BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics, reports
SKYX Reports Record Second Quarter Sales of $21.4 Million Compared to $15.0 Million for Second Quarter 2023 as it Continues to Grow its Market Penetration in the U.S and Canada of its Advanced and Smart Platform Products
MIAMI, FL, August 12, 2024 – SKYX Platforms Corp. (NASDAQ: SKYX) (d/b/a SKYX Technologies) (the “Company” or “SKYX”), a highly disruptive platform technology company with
AB INTL GROUP Reports of Financial Results for period ending May 31, 2024 and achieved Net Profitability
NEW YORK, August 12, 2024 — AB International Group Corp. (OTC: ABQQ), an intellectual property (IP) and movie investment and licensing firm, announces its financial
StemSation International Provides Corporate Updates
StemSation International is providing updates on corporate planning and direction as they execute on an expanded business model Plantation, Florida, August 12, 2024 – StemSation
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
Top Line Data Expected Year-End 2024 Pittsburgh, August 12, 2024 — Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” “we” or the “Company”), a clinical-stage
ANEW MEDICAL, INC. Pursues Neurological Approach to Treating Weight Loss and Eating Disorders through Melanocortin Receptor Binding Peptides
NEW YORK, NY, August 09, 2024 – ANEW MEDICAL, INC. (NASDAQ: WENA) has announced that, as a result of its worldwide licensing agreement with Teleost
Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results
Interest in kidney transplant assay represents approximately 25% of US transplant volume Company lays out land and expand strategy in transplant IRVINE, Calif., August 8,
ANEW MEDICAL, INC. Announces Patents Issued in Major Asian Markets for use of Genetic Therapy in the Treatment of Alzheimer’s Disease and ALS
New York, NY, August 8, 2024 – ANEW MEDICAL, INC. (“ANEW” or “the Company”) (NASDAQ: WENA) a US-based biotechnology company focused on developing cell- and
Premier Graphene President Pedro Mendez Meets with Global Leader in Sustainable Construction
Premier’s Graphene Suspensions Receiving Interest from one of the World’s Largest Materials Handling Companies EL CENTRO, California, August 8, 2024 – Premier Graphene, Inc. (OTC
BLAQclouds, Inc. Announces Intent to Acquire ZEUS Blockchain Partners
Las Vegas, NV, August 07, 2024 — BLAQclouds, Inc. (OTC: BCDS) is pleased to announce the intent to acquire the equity of ZEUS Blockchain Partners,
SKYX Announces Corporate Update Call
Company to Provide Corporate Updates Including Second Quarter 2024 Financial Results; Conference Call to be Held on Monday, August 12, 2024 at 4:30 PM Eastern
Hollywood Star Cuts Expands Through Strategic Agreement With Utah Based Haircare Franchise Group
Las Vegas, NV, August 7, 2024 – All American Gold Corp. (OTC: AAGC) is very excited to update the public about AAGC’s agreement with an existing
REMSleep Holdings Inc. Issues Shareholder Letter
Company Unveils Internal Corporate Goal of Capturing 10% of the CPAP Mask Market Within 24 Months CLEARWATER, Fla., August 6, 2024 – REMSleep Holdings, Inc.
American Shared Hospital Services Announces Start of Patient Treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla, in Puebla, Mexico
SAN FRANCISCO, CA, August 6, 2024 ‒ American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic
Oncocyte Announces August Investor Conferences Participation
IRVINE, Calif., August 5, 2024 — Oncocyte Corp. (Nasdaq: OCX), a molecular diagnostics technology company, today announced that CEO Josh Riggs and CFO Andrea James
Vocodia Holdings Announces $2.8 million Preferred Stock Purchase Agreement as part of a $3.0 million Capital Raise
Boca Raton, FL, August 5, 2024 – Vocodia Holdings Corp (CBOE: VHAI) (“Vocodia” or the “Company”) a leader in AI software development focusing on practical
BioStem Technologies to Report Second Quarter 2024 Financial Results on Monday, August 12, 2024
Conference Call and Webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., August 5, 2024, — BioStem Technologies, Inc. (OTC: BSEM), a leading
Direct Equity Source Announces Strategic Partnership with AAA Storage to Expand Self-Storage Portfolio
Austin, Texas, August 2, 2024 – Direct Equity Source, a leading real estate private equity firm, is pleased to announce a strategic partnership with AAA
Vocodia’s Demos Offer Human-Like AI Interactions
Chicago, August 2, 2024 — Vocodia Holdings Corp. (CBOE: VHAI), a pioneering AI software company specializing in practical AI solutions, today invites the public to
Contact Us
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850